TABLE 1.
Patient no. | Antibody titer at the following mo of follow-up
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 6 | 12 | 18 | 24 | 30 | 36 | 42 | 48 | 54 | 60 | 66 | |
1 | 1,024 | 1,024 | 1,024 | 512 | 128 | 64 | NDa | ND | ND | ND | ND | ND |
2 | 128 | 32 | 32 | 32 | 32 | 32 | ND | ND | ND | ND | ND | ND |
3 | 1,024 | 512 | 512 | 128 | 128 | 128 | 128 | 128 | 128 | 128 | ND | ND |
6 | 1,024 | 1,024 | 512 | ND | 512 | 64 | 64 | 128 | 128 | 128 | ND | ND |
7 | 1,024 | 512 | 1,024 | ND | 256 | 128 | 128 | 256 | ND | ND | ND | ND |
9 | 64 | 64 | 64 | 32 | 64 | 16 | 16 | 32 | 16 | 8 | ND | 8 |
13 | 1,024 | ND | 2,048 | 512 | 1,024 | 512 | 64 | 64 | 512 | 256 | 256 | ND |
15 | 1,024 | 128 | 512 | ND | 32 | 256 | 256 | ND | ND | ND | ND | ND |
16 | 2,048 | 512 | 512 | 512 | 128 | 64 | 64 | 64 | 64 | 64 | ND | 64 |
ND, not determined.